| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Feb―08 |
Acute and postacute COVID-19 outcomes for patients with rheumatoid arthritis: lessons learned and emerging directions 3 years into the pandemic |
Alessandra Zaccardelli, Zachary S. Wallace, Jeffrey A. Sparks |
| 2 |
[GO] |
2022―Sep―12 |
A cursed goodbye kiss from severe acute respiratory syndrome-coronavirus-2 to its pediatric hosts: multisystem inflammatory syndrome in children |
Fatih Haslak, Aybuke Gunalp, Ozgur Kasapcopur |
| 3 |
[GO] |
2022―Jul―05 |
Complications of severe acute respiratory syndrome coronavirus 2 infection in children |
Roberta Caorsi, Adele Civino, Angelo Ravelli |
| 4 |
[GO] |
2021―Dez―15 |
Gout and the COVID-19 pandemic |
Vicky Tai, Philip C. Robinson, Nicola Dalbeth |
| 5 |
[GO] |
2021―Okt―26 |
Did COVID-19 impact osteoarthritis - clinical perspective? |
Eaman Alhassan, Bernadette C. Siaton, Marc C. Hochberg |
| 6 |
[GO] |
2021―Jul―15 |
Is severe COVID-19 a cytokine storm syndrome |
Puja Mehta, David C. Fajgenbaum |
| 7 |
[GO] |
2021―Jul―14 |
The role of immunomodulatory medications in the treatment of COVID-19 |
Sebastian E. Sattui, Mary K. Crow, Iris Navarro-Millán |
| 8 |
[GO] |
2021―Jun―27 |
The impact of the COVID-19 pandemic on the field of pediatric rheumatology |
Dawn M. Wahezi, Malki Peskin, Tamara Tanner |
| 9 |
[GO] |
2021―Jun―27 |
Rheumatology at the center of coronavirus disease 2019 |
Rebecca H. Haberman, Brian D. Jaros, Jose U. Scher |
| 10 |
[GO] |
2021―Jun―26 |
Coronavirus disease 2019 |
Jeffrey A. Sparks, Zachary S. Wallace, Philip C. Robinson |
| 11 |
[GO] |
2021―Feb―27 |
COVID-19 and rheumatoid arthritis |
Kristin M. D'Silva, Zachary S. Wallace |
| 12 |
[GO] |
2021―Jan―01 |
Global research collaboration in a pandemic-challenges and opportunities |
Philip C. Robinson, Jinoos Yazdany, Pedro M. Machado |
| 13 |
[GO] |
2020―Dez―17 |
COVID-19 and autoimmune diseases |
Yu Liu, Amr H. Sawalha, Qianjin Lu |
| 14 |
[GO] |
2020―Nov―23 |
Coronavirus 2019 |
David S. Younger |
| 15 |
[GO] |
2020―Jul―28 |
COVID-19: a primer for the rheumatologist: management of patients and care settings |
Cassandra Calabrese, Bethany Lehman |
| 16 |
[GO] |
2020―Jul―16 |
Role for antimalarials in the management of COVID-19 |
Eva V. Schrezenmeier, Gerd R. Burmester, Kai-Uwe Eckardt, Thomas Dörner |
| 17 |
[GO] |
2020―Jul―16 |
Reflections on rheumatological aspects of COVID-19 |
Leonard H. Calabrese, Cassandra Calabrese |
| 18 |
[GO] |
2020―Jul―16 |
Epidemiology and outcomes of novel coronavirus 2019 in patients with immune-mediated inflammatory diseases |
Milena Gianfrancesco, Jinoos Yazdany, Philip C. Robinson |
| 19 |
[GO] |
2020―Jul―16 |
Tracking clinical resources for coronavirus disease 2019 |
Garret Duron, Lauren Gelman, Anisha Dua, Michael Putman |
| 20 |
[GO] |
2020―Jul―13 |
Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement |
Kamran Kadkhoda |
